Perioperative outcomes of patients undergoing urological elective surgery during the COVID-19 pandemic: a national overview across 28 Italian institutions.
COVID-19
coronavirus
infection
outcome
surgery
urology
Journal
Central European journal of urology
ISSN: 2080-4806
Titre abrégé: Cent European J Urol
Pays: Poland
ID NLM: 101587101
Informations de publication
Date de publication:
2021
2021
Historique:
received:
24
12
2020
revised:
02
03
2021
accepted:
08
04
2021
entrez:
2
8
2021
pubmed:
3
8
2021
medline:
3
8
2021
Statut:
ppublish
Résumé
The aim of this study was to assess the safety of elective urological surgery performed during the pandemic by estimating the prevalence of COVID-19-like symptoms in the postoperative period and its correlation with perioperative and clinical factors. In this multicenter, observational study we recorded clinical, surgical and postoperative data of consecutive patients undergoing elective urological surgery in 28 different institutions across Italy during initial stage of the COVID-19 pandemic (between February 24 and March 30, 2020, inclusive). A total of 1943 patients were enrolled. In 12%, 7.1%, 21.3%, 56.7% and 2.6% of cases an open, laparoscopic, robotic, endoscopic or percutaneous surgical approach was performed, respectively. Overall, 166 (8.5%) postoperative complications were registered, 77 (3.9%) surgical and 89 (4.6%) medical. Twenty-eight (1.4%) patients were readmitted to hospital after discharge and 13 (0.7%) died. In the 30 days following discharge, fever and respiratory symptoms were recorded in 101 (5.2%) and 60 (3.1%) patients. At multivariable analysis, not performing nasopharyngeal swab at hospital admission (HR 2.3; CI 95% 1.01-5.19; p = 0.04) was independently associated with risk of developing postoperative medical complications. Number of patients in the facility was confirmed as an independent predictor of experiencing postoperative respiratory symptoms (p = 0.047, HR:1.12; CI95% 1.00-1.05), while COVID-19-free type of hospitalization facility was a strong independent protective factor (p = 0.02, HR:0.23, CI95% 0.07-0.79). Performing elective surgery during the COVID-19 pandemic does not seem to affect perioperative outcomes as long as proper preventive measures are adopted, including nasopharyngeal swab before hospital admission and hospitalization in dedicated COVID-19-free facilities.
Identifiants
pubmed: 34336248
doi: 10.5173/ceju.2021.0374
pii: 0374
pmc: PMC8318031
doi:
Types de publication
Journal Article
Langues
eng
Pagination
259-268Informations de copyright
Copyright by Polish Urological Association.
Déclaration de conflit d'intérêts
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
Références
World J Urol. 2021 Jun;39(6):1985-1989
pubmed: 32447443
Eur Urol. 2020 Jun;77(6):663-666
pubmed: 32279903
Eur J Cancer. 2020 Jun;132:5-7
pubmed: 32302754
Int Braz J Urol. 2020 Jul;46(suppl.1):3-5
pubmed: 32649081
Eur J Surg Oncol. 2020 Jun;46(6):1196-1197
pubmed: 32362468
Eur Urol. 2020 Jul;78(1):11-15
pubmed: 32307215
Lancet. 2020 Feb 22;395(10224):542-545
pubmed: 32061313
Int J Surg. 2020 Jun;78:5-6
pubmed: 32302745
Int Urol Nephrol. 2020 Nov;52(11):2059-2064
pubmed: 32583371
JAMA. 2020 May 19;323(19):1908-1909
pubmed: 32275299
JAMA Oncol. 2020 Sep 1;6(9):1330-1331
pubmed: 32379856
EClinicalMedicine. 2020 Apr 27;22:100362
pubmed: 32342039
Cent European J Urol. 2020;73(3):269-272
pubmed: 33133652
Int Urol Nephrol. 2020 Aug;52(8):1499-1500
pubmed: 32472250
Surg Endosc. 2020 Jun;34(6):2327-2331
pubmed: 32323016
Eur J Surg Oncol. 2020 Nov;46(11):2154-2155
pubmed: 32409112
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
World J Urol. 2020 Jul 4;:
pubmed: 32623500
Surg Endosc. 2021 May;35(5):2217-2222
pubmed: 32399942
Surg Endosc. 2020 Oct;34(10):4225-4232
pubmed: 32749615
Eur J Surg Oncol. 2020 Jun;46(6):1188
pubmed: 32371041
Int Braz J Urol. 2020 Jul;46(suppl.1):170-180
pubmed: 32649082
Cent European J Urol. 2020;73(3):252-259
pubmed: 33133649
Eur J Surg Oncol. 2020 Jun;46(6):1186-1187
pubmed: 32336627
World J Urol. 2020 May 27;:
pubmed: 32462305
Int Braz J Urol. 2020 Jul;46(suppl.1):34-38
pubmed: 32550701
Urol Int. 2020;104(7-8):631-636
pubmed: 32434207
Cent European J Urol. 2020;73(3):260-264
pubmed: 33133650
World J Urol. 2021 Jun;39(6):1789-1796
pubmed: 32776243
Surg Endosc. 2020 Aug;34(8):3292-3297
pubmed: 32394175
Int Braz J Urol. 2021 Mar-Apr;47(2):251-262
pubmed: 32840335